Patents by Inventor Yoshitaka Sekido

Yoshitaka Sekido has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
    Patent number: 7781413
    Abstract: The present invention identifies the semaphorin polypeptide SEMA3B as a tumor suppressor. This molecule can inhibit tumor growth and induce apoptosis of tumor cells when produced internally in a cancer cell via gene transfer, or when applied extracellularly. These observations permit new methods for treatment and diagnosis of cancer.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: August 24, 2010
    Assignee: Board of Regents, The University of Texas System
    Inventors: John Minna, Yoshio Tomizawa, Yoshitaka Sekido, Michael Lerman
  • Calcium channel proteins
    Patent number: 6979724
    Abstract: The present invention relates to calcium channel compositions and methods of making and using same. In particular, the invention relates to calcium channel alpha2delta (?2?) subunits and nucleic acid sequences encoding them. These compositions are useful in methods for identifying compounds that modulate the activity of calcium channels and for identifying compounds as therapeutic for disease.
    Type: Grant
    Filed: April 5, 2002
    Date of Patent: December 27, 2005
    Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, The Board of Regents of the University of Texas System
    Inventors: Michael Isaac Lerman, Farida Latif, Ming-Hui Wei, Fuh-Mei Duh, John Dorrance Minna, Yoshitaka Sekido, Boning Gao
  • SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
    Publication number: 20030166557
    Abstract: The present invention identifies the semaphorin polypeptide SEMA3B as a tumor suppressor. This molecule can inhibit tumor growth and induce apoptosis of tumor cells when produced internally in a cancer cell via gene transfer, or when applied extracellularly. These observations permit new methods for treatment and diagnosis of cancer.
    Type: Application
    Filed: October 31, 2002
    Publication date: September 4, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: John Minna, Yoshio Tomizawa, Yoshitaka Sekido, Michael Lerman
  • Calcium channel compositions and methods of use thereof
    Publication number: 20030044911
    Abstract: The present invention relates to calcium channel compositions and methods of making and using same. In particular, the invention relates to calcium channel alpha2delta (&agr;2&dgr;) subunits and nucleic acid sequences encoding them. These compositions are useful in methods for identifying compounds that modulate the activity of calcium channels and for identifying compounds as therapeutic for disease.
    Type: Application
    Filed: April 5, 2002
    Publication date: March 6, 2003
    Inventors: Michael Isaac Lerman, Farida Latif, Ming-Hui Wei, Fuh-Mei Duh, John Dorrance Minna, Yoshitaka Sekido, Boning Gao
  • Calcium channel compositions and methods of use thereof
    Patent number: 6441156
    Abstract: The present invention relates to calcium channel compositions and methods of making and using same. In particular, the invention relates to calcium channel alpha2delta (&agr;2&dgr;) subunits and nucleic acid sequences encoding them. These compositions are useful in methods for identifying compounds that modulate the activity of calcium channels and for identifying compounds as therapeutic for disease.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: August 27, 2002
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Michael Isaac Lerman, Farida Latif, Ming-Hui Wei, Fuh-Mei Duh, John Dorrance Minna, Yoshitaka Sekido, Boning Gao